Table 3 Overall survival (OS)and DFS by treatment at 72 months (N=1669)

From: Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

 

No. of patients

No. of events

6-year DFS% (s.e.)

P

No. dead

6-year OS% (s.e.)

P

Overall

       

 Tam

846

166

>78 (2)

0.05

94

>87 (1)

0.07

 CMF → Tam

823

138

>83 (1)

 

73

>91 (1)

 

ER-negative

       

 Tam

190

57

>67 (4)

0.003

38

>75 (4)

0.01

 CMF → Tam

192

33

>83 (3)

 

21

>88 (3)

 

ER-positive

       

 Tam

621

101

>81 (2)

0.92

51

>90 (2)

0.80

 CMF → Tam

596

101

>82 (2)

 

50

>92 (1)

 
  1. DFS=disease-free survival; s.e.=standard error.
Back to article page